Editorial Comment: Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer
Standard
In: J UROLOGY, Vol. 205, No. 2, 02.2021, p. 460.
Research output: SCORING: Contribution to journal › Editorial › Research
Harvard
Tilki, D 2021, 'Editorial Comment: Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer', J UROLOGY, vol. 205, no. 2, pp. 460. https://doi.org/10.1097/JU.0000000000001361.02
APA
Tilki, D. (2021). Editorial Comment: Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J UROLOGY, 205(2), 460. https://doi.org/10.1097/JU.0000000000001361.02
Vancouver
Tilki D. Editorial Comment: Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J UROLOGY. 2021 Feb;205(2):460. https://doi.org/10.1097/JU.0000000000001361.02
Bibtex
@article{cd7c7e501646453c8a2679e725af357e,
title = "Editorial Comment: Clinical Utility of 4Kscore{\textregistered}, ExosomeDx{\texttrademark} and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer",
author = "Derya Tilki",
year = "2021",
month = feb,
doi = "10.1097/JU.0000000000001361.02",
language = "English",
volume = "205",
pages = "460",
journal = "J UROLOGY",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",
}
RIS
TY - JOUR
T1 - Editorial Comment: Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer
AU - Tilki, Derya
PY - 2021/2
Y1 - 2021/2
U2 - 10.1097/JU.0000000000001361.02
DO - 10.1097/JU.0000000000001361.02
M3 - Editorial
C2 - 33238831
VL - 205
SP - 460
JO - J UROLOGY
JF - J UROLOGY
SN - 0022-5347
IS - 2
ER -
